跳至主導覽
跳至搜尋
跳過主要內容
國立成功大學 首頁
English
中文
在 國立成功大學 搜尋內容
首頁
概要
研究單位
研究成果
專案
學生論文
設備
獎項
活動
查看斯高帕斯 (Scopus) 概要
蘇 佩芳
教授
數據科學研究所
電話
886 6 2757575 ext 53623
電子郵件
pfsu
mail.ncku.edu
tw
h-index
3228
引文
21
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2001
2026
每年研究成果
概覽
指紋
網路
專案
(9)
研究成果
(120)
類似的個人檔案
(6)
監製作品
(15)
指紋
查看啟用 Pei-Fang Su 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Cardiovascular Disease
100%
Non Insulin Dependent Diabetes Mellitus
97%
Malignant Neoplasm
83%
Cohort Study
78%
Breast Cancer
72%
Chemotherapy
54%
Atosiban
48%
Endometriosis
48%
Deterioration
38%
Tumor Recurrence
36%
Retinopathy
32%
Non Small Cell Lung Cancer
32%
Neoplasm
31%
Dipeptidyl Peptidase IV Inhibitor
28%
Coronary Artery Disease
27%
Cardiovascular Mortality
26%
Urinary Tract Infection
24%
Diabetic Retinopathy
24%
Hepatitis B Antigen
24%
Postoperative Complication
24%
Recombinant Chorionic Gonadotropin
24%
Acute Pancreatitis
24%
Nitric Oxide Donor
24%
Seborrheic Keratosis
24%
Carbon Dioxide
24%
Insulin Dependent Diabetes Mellitus
24%
Entecavir
24%
Chronic Hepatitis B
24%
Hydroxychloroquine
24%
Sulfonylurea
24%
Activated Leukocyte Cell Adhesion Molecule
24%
Nitric Oxide
24%
Cardiovascular Risk
24%
Scatter Factor Receptor
24%
Pandemic
24%
Tolerability
24%
Nephrolithiasis
24%
Kidney Stone
24%
Adult Respiratory Distress Syndrome
24%
QT Prolongation
24%
Repurposing
24%
Hemodialysis
24%
Chronic Obstructive Lung Disease
24%
Bleeding
24%
Endometrium Cancer
24%
Survival Time
24%
Sodium Glucose Cotransporter 2 Inhibitor
24%
Heart Ventricle Extrasystole
24%
Abdominal Obesity
24%
Microangiopathy
24%
Medicine and Dentistry
Maturity Onset Diabetes of the Young
74%
Quality of Life
72%
Propensity Score Matching
60%
Neoplasm
54%
Colorectal Carcinoma
48%
Pancreaticoduodenectomy
48%
Cardiovascular Disease
48%
Endometriosis
48%
Breast Cancer
48%
Cancer Therapy
48%
Computer Assisted Tomography
48%
Hazard Ratio
48%
Retrospective Cohort Study
39%
Cardiovascular System
34%
Health Care Cost
32%
Retinopathy
29%
Deterioration
29%
Percutaneous Coronary Intervention
28%
Gamma Urogastrone
27%
Epidermal Growth Factor Receptor 2
27%
Esophagus Pressure
26%
Odds Ratio
26%
Patient with Type 2 Diabetes
25%
Diseases
24%
Symptomatic Treatment
24%
Cardiovascular Mortality
24%
Abdominal Obesity
24%
Rotator Cuff
24%
Diabetic Retinopathy
24%
Peritonitis
24%
Peritoneal Dialysis
24%
Breathing
24%
Survival Analysis
24%
Myasthenia gravis
24%
Kidney Function
24%
Seborrheic Keratosis
24%
Patient with Type 1 Diabetes
24%
Cervical Collar
24%
Activated Leukocyte Cell Adhesion Molecule
24%
In-Stent Restenosis
24%
Chronic Obstructive Pulmonary Disease
24%
Uterine Cancer
24%
Microvascular Decompression
24%
Trigeminal Neuralgia
24%
Dialysis Catheter
24%
Scatter Factor Receptor
24%
Oligomer
24%
Kidney Stone
24%
Genetic Risk
24%
Drug-Eluting Stent
24%
Keyphrases
Recurrent Event Data
72%
Recurrent Events
48%
Taiwan
41%
Embryo Transfer Cycle
29%
University Hospital
29%
Hospice Patients
26%
Repair Tension
24%
Regression Model
24%
Nomogram Model
24%
Skew-normal
24%
R Control Chart
24%
CO2 Monitoring
24%
Spatial Random Effects
24%
Pathological Classification
24%
Government Subsidy
24%
Batch Effects
24%
Mitoflash
24%
Mitochondrial Flash
24%
Weighted Kaplan-Meier
24%
Seborrheic Keratosis
24%
Additive Rate Model
24%
Quality of Life
24%
Spatial Survival
24%
Minimally Invasive Pancreaticoduodenectomy
24%
Proportional Rate
24%
Infertility Treatment
24%
Adaptive Treatment
24%
Activated Leukocyte Cell Adhesion Molecule
24%
Idiopathic Trigeminal Neuralgia
24%
Pain Improvement
24%
Mucinous Differentiation
24%
Omics Data Analysis
24%
Microvascular Decompression
24%
Random Covariates
24%
Statistical Aspects
24%
Recepteur D'origine Nantais
24%
Patients with Colorectal Cancer
24%
MET Receptor
24%
Colorectal mucinous Adenocarcinoma
24%
Multinomial
24%
Adaptive Treatment Allocation
24%
Serous Adenocarcinoma
24%
Recurrent Endometrial Cancer
24%
In Vitro Fertilization-embryo Transfer (IVF-ET)
24%
Radiology Reports
24%
Quantitative Metrics
24%
Nitric Oxide-donating
24%
Clinical Radiology
24%
Moncrief-Popovich Technique
24%
Small RNA Deep Sequencing
24%
